Dr David Scott |
Senior Research Fellow Dr David
Scott from the School of Clinical Sciences at Monash Health (SCS) has been
awarded a Rebecca L. Cooper Medical Research Foundation Project Grant to support
his research into sarcopenia.
Sarcopenia is the degenerative
loss of skeletal muscle mass and function.
It is estimated that 5–13% of elderly
people aged 60–70 years are affected by sarcopenia, and this increases to
11–50% for those aged over 80.
Dr Scott, an NHRMC Career Development Fellow in the Bone and Muscle
Health Research Group, will use the $100,000 grant to undertake a
randomised controlled trial comparing the effects of weight loss plus a
bone-targeted exercise intervention versus weight loss alone in obese older
adults with sarcopenia.
“We have demonstrated previously
that obese older adults with sarcopenia have increased risk for falls,
fractures and type 2 diabetes,” Dr Scott said.
“These individuals can undoubtedly
benefit from weight loss interventions, but can experience significant losses
of bone and muscle mass as a result.”
“We will determine whether a
12-week bone-targeted exercise intervention involving high-velocity resistance
training and impact activities prevents decreases in bone and muscle mass
during weight loss,” he said.
“We will also explore whether this
type of exercise enhances the benefits of weight loss for improving insulin
sensitivity in obese older adults with sarcopenia.”
Dr Scott’s application was the
top-ranked grant in the geriatrics discipline.
He has also been invited to attend the Rebecca L. Cooper Medical
Research Foundation dinner in Sydney next month.
Dr Scott acknowledges the ongoing
support of Professor Peter Ebeling and the team in the Bone and Muscle Health
Research Group.
No comments:
Post a Comment